{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:42:35Z","timestamp":1794649355035,"version":"4.9.1"},"reference-count":101,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T00:00:00Z","timestamp":1661904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Diabetes Research and Wellness Foundation the UK","award":["IFPIP: 1031-247-1442"],"award-info":[{"award-number":["IFPIP: 1031-247-1442"]}]},{"name":"Diabetes Research Fund at Queen Elizabeth Hospital, Gateshead, UK","award":["IFPIP: 1031-247-1442"],"award-info":[{"award-number":["IFPIP: 1031-247-1442"]}]},{"name":"Institutional Fund Projects","award":["IFPIP: 1031-247-1442"],"award-info":[{"award-number":["IFPIP: 1031-247-1442"]}]},{"name":"ministry of Education and King Abdulaziz University","award":["IFPIP: 1031-247-1442"],"award-info":[{"award-number":["IFPIP: 1031-247-1442"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Colony forming unit-Hill\u2019s (CFU-Hill\u2019s) colonies are hematopoietic-derived cells that participate in neovasculogenesis and serve as a biomarker for vascular health. In animals, overexpression of miR-18a-5p was shown to be pro-atherogenic. We had shown that well-controlled type 1 diabetes mellitus (T1DM) is characterized by an inflammatory state, endothelial dysfunction, and reduced number of CFU-Hill\u2019s, a model of subclinical cardiovascular disease (CVD). MERIT study explored the role of miR-18a-5p expression in CFU-Hill\u2019s colonies in T1DM, and the cardioprotective effect of metformin in subclinical CVD. In T1DM, miR-18a-5p was significantly upregulated whereas metformin reduced it to HC levels. MiR-18a-5p was inversely correlated with CFU-Hill\u2019s colonies, CD34+, CD34+CD133+ cells, and positively with IL-10, C-reactive protein, vascular endothelial growth factor-D (VEGF-D), and thrombomodulin. The receiver operating characteristic curve demonstrated, miR-18a-5p as a biomarker of T1DM, and upregulated miR-18a-5p defining subclinical CVD at HbA1c of 44.5 mmol\/mol (pre-diabetes). Ingenuity pathway analysis documented miR-18a-5p inhibiting mRNA expression of insulin-like growth factor-1, estrogen receptor-1, hypoxia-inducible factor-1\u03b1 cellular communication network factor-2, and protein inhibitor of activated STAT 3, whilst metformin upregulated these mRNAs via transforming growth factor beta-1 and VEGF. We confirmed the pro-atherogenic effect of miR-18a-5p in subclinical CVD and identified several target genes for future CVD therapies.<\/jats:p>","DOI":"10.3390\/biomedicines10092136","type":"journal-article","created":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T23:53:21Z","timestamp":1661990001000},"page":"2136","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Upregulated miR-18a-5p in Colony Forming Unit-Hill\u2019s in Subclinical Cardiovascular Disease and Metformin Therapy; MERIT Study"],"prefix":"10.3390","volume":"10","author":[{"given":"Jason","family":"Phowira","sequence":"first","affiliation":[{"name":"Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK"},{"name":"Faculty of Medicine, Universitas Indonesia, Jakarta 10430, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad W.","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK"},{"name":"Department of Diabetes, Queen Elizabeth Hospital, Gateshead, Newcastle upon Tyne NE9 6SH, UK"},{"name":"Department of Medical Oncology, King Faisal Specialist Hospital and Research Centre, Madinah 42522, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1580-0409","authenticated-orcid":false,"given":"Sherin","family":"Bakhashab","sequence":"additional","affiliation":[{"name":"Biochemistry Department, King Abdulaziz University, P.O. Box 80218, Jeddah 21589, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta U.","family":"Weaver","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK"},{"name":"Department of Diabetes, Queen Elizabeth Hospital, Gateshead, Newcastle upon Tyne NE9 6SH, UK"},{"name":"Vascular Biology and Medicine Theme, Newcastle University, Newcastle upon Tyne NE1 7RU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,31]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2022, August 20). Cardiovascular Diseases (CVDs), Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds)."},{"key":"ref_2","unstructured":"World Health Organization (2021, February 10). The Challenge of Cardiovascular Disease\u2014Quick Statistics, Available online: https:\/\/www.euro.who.int\/en\/health-topics\/noncommunicable-diseases\/cardiovascular-diseases\/data-and-statistics."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12933-019-0953-7","article-title":"Risk of early mortality and cardiovascular disease in type 1 diabetes: A comparison with type 2 diabetes, a nationwide study","volume":"18","author":"Lee","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jama.2014.16425","article-title":"Estimated Life Expectancy in a Scottish Cohort with Type 1 Diabetes, 2008\u20132010","volume":"313","author":"Livingstone","year":"2015","journal-title":"JAMA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJMoa1408214","article-title":"Glycemic Control and Excess Mortality in Type 1 Diabetes","volume":"371","author":"Lind","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12933-016-0413-6","article-title":"Metformin improves circulating endothelial cells and endothelial progenitor cells in type 1 diabetes: MERIT study","volume":"15","author":"Ahmed","year":"2016","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1530\/EJE-09-0795","article-title":"Circulating endothelial cells are elevated in patients with type 1 diabetes mellitus","volume":"162","author":"Asicioglu","year":"2010","journal-title":"Eur. J. Endocrinol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1056\/NEJMoa022287","article-title":"Circulating endothelial progenitor cells, vascular function, and cardiovascular risk","volume":"348","author":"Hill","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1007\/s00125-009-1401-0","article-title":"Circulating endothelial progenitor cells, endothelial function, carotid intima-media thickness and circulating markers of endothelial dysfunction in people with type 1 diabetes without macrovascular disease or microalbuminuria","volume":"52","author":"Sibal","year":"2009","journal-title":"Diabetologia"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1210\/jc.2009-1993","article-title":"Inflammatory markers are increased in youth with type 1 diabetes: The SEARCH Case-Control study","volume":"95","author":"West","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12933-015-0235-y","article-title":"The inflammation, vascular repair and injury responses to exercise in fit males with and without Type 1 diabetes: An observational study","volume":"14","author":"West","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1126\/science.275.5302.964","article-title":"Isolation of putative progenitor endothelial cells for angiogenesis","volume":"275","author":"Asahara","year":"1997","journal-title":"Science"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"a006692","DOI":"10.1101\/cshperspect.a006692","article-title":"Human endothelial progenitor cells","volume":"2","author":"Yoder","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.2741\/4055","article-title":"Endothelial progenitor cells in atherosclerosis","volume":"17","author":"Du","year":"2012","journal-title":"Front. Biosci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1161\/01.ATV.0000114236.77009.06","article-title":"Characterization of Two Types of Endothelial Progenitor Cells and Their Different Contributions to Neovasculogenesis","volume":"24","author":"Hur","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1182\/blood-2006-08-043471","article-title":"Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem\/progenitor cell principals","volume":"109","author":"Yoder","year":"2007","journal-title":"Blood"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.numecd.2016.03.010","article-title":"Number of colony-forming unit-Hill colonies among children and teenagers with obesity, dyslipidemia and breastfeeding history","volume":"26","year":"2016","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/ijo.2008.262","article-title":"Endothelial progenitor cell number and colony-forming capacity in overweight and obese adults","volume":"33","author":"MacEneaney","year":"2008","journal-title":"Int. J. Obes."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"UK Prospective Diabetes Study (UKPDS) Group (1998). Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet, 352, 854\u2013865.","DOI":"10.1016\/S0140-6736(98)07037-8"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Salvatore, T., Galiero, R., Caturano, A., Vetrano, E., Rinaldi, L., Coviello, F., Di Martino, A., Albanese, G., Marfella, R., and Sardu, C. (2021). Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence. Biomolecules, 11.","DOI":"10.3390\/biom11121834"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Salvatore, T., Pafundi, P.C., Galiero, R., Rinaldi, L., Caturano, A., Vetrano, E., Aprea, C., Albanese, G., Di Martino, A., and Ricozzi, C. (2020). Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects?. Biomedicines, 9.","DOI":"10.3390\/biomedicines9010003"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/FJC.0b013e31819fd4e7","article-title":"Metformin Prevents Myocardial Reperfusion Injury by Activating the Adenosine Receptor","volume":"53","author":"Paiva","year":"2009","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1139\/bcb-2018-0027","article-title":"MicroRNAs in type 1 diabetes: New research progress and potential directions","volume":"96","author":"Miao","year":"2018","journal-title":"Biochem. Cell Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1530\/EC-17-0248","article-title":"MicroRNA expression profiles and type 1 diabetes mellitus: Systematic review and bioinformatic analysis","volume":"6","author":"Assmann","year":"2017","journal-title":"Endocr. Connect."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4070\/kcj.2014.44.4.255","article-title":"miR-18a-5p MicroRNA Increases Vascular Smooth Muscle Cell Differentiation by Downregulating Syndecan4","volume":"44","author":"Kee","year":"2014","journal-title":"Korean Circ. J."},{"key":"ref_26","first-page":"e924625","article-title":"miR-18a-5p Promotes Proliferation and Migration of Vascular Smooth Muscle Cells by Activating the AKT\/Extracellular Regulated Protein Kinases (ERK) Signaling Pathway","volume":"26","author":"Zhang","year":"2020","journal-title":"Med. Sci. Monit."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3389\/fphar.2020.00276","article-title":"MicroRNA-18a-5p Administration Suppresses Retinal Neovascularization by Targeting FGF1 and HIF1A","volume":"11","author":"Guan","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa043814","article-title":"Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes","volume":"353","author":"Werner","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1182\/blood-2005-04-1509","article-title":"Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells","volume":"106","author":"Ingram","year":"2005","journal-title":"Blood"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s13287-021-02332-7","article-title":"Upregulated anti-angiogenic miR-424-5p in type 1 diabetes (model of subclinical cardiovascular disease) correlates with endothelial progenitor cells, CXCR1\/2 and other parameters of vascular health","volume":"12","author":"Tamara","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.biocel.2017.07.020","article-title":"miR-18a induces myotubes atrophy by down-regulating IgfI","volume":"90","author":"Liu","year":"2017","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"15330338211043976","DOI":"10.1177\/15330338211043976","article-title":"MiR-18a-5p Facilitates Progression of Hepatocellular Carcinoma by Targeting CPEB3","volume":"20","author":"Cui","year":"2021","journal-title":"Technol. Cancer Res. Treat."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/ng1855","article-title":"Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster","volume":"38","author":"Dews","year":"2006","journal-title":"Nat. Genet."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/bjc.2012.587","article-title":"MicroRNA-18a modulates STAT3 activity through negative regulation of PIAS3 during gastric adenocarcinogenesis","volume":"108","author":"Wu","year":"2013","journal-title":"Br. J. Cancer"},{"key":"ref_35","first-page":"1873","article-title":"Luteinizing hormone facilitates angiogenesis in ovarian epithelial tumor cells and metformin inhibits the effect through the mTOR signaling pathway","volume":"27","author":"Liao","year":"2012","journal-title":"Oncol. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1593\/neo.11148","article-title":"Metformin Suppresses Ovarian Cancer Growth and Metastasis with Enhancement of Cisplatin Cytotoxicity In Vivo","volume":"13","author":"Rattan","year":"2011","journal-title":"Neoplasia"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/cvr\/cvq066","article-title":"Metformin attenuates cardiac fibrosis by inhibiting the TGFbeta1-Smad3 signalling pathway","volume":"87","author":"Xiao","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ymthe.2016.12.017","article-title":"miR-18a-5p Inhibits Sub-pleural Pulmonary Fibrosis by Targeting TGF-beta Receptor II","volume":"25","author":"Zhang","year":"2017","journal-title":"Mol. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"de Candia, P., Spinetti, G., Specchia, C., Sangalli, E., La Sala, L., Uccellatore, A., Lupini, S., Genovese, S., Matarese, G., and Ceriello, A. (2017). A unique plasma microRNA profile defines type 2 diabetes progression. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0188980"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"5998","DOI":"10.1038\/s41598-017-05787-y","article-title":"Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes","volume":"7","author":"Shah","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.diabres.2018.03.044","article-title":"MicroRNA expression profile in plasma from type 1 diabetic patients: Case-control study and bioinformatic analysis","volume":"141","author":"Assmann","year":"2018","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e89656","DOI":"10.1172\/jci.insight.89656","article-title":"Profiling of circulating microRNAs in children with recent onset of type 1 diabetes","volume":"2","author":"Erener","year":"2017","journal-title":"JCI Insight"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.3389\/fonc.2020.01567","article-title":"Early-Onset Diabetes as Risk Factor for Pancreatic Cancer: miRNA Expression Profiling in Plasma Uncovers a Role for miR-20b-5p, miR-29a, and miR-18a-5p in Diabetes of Recent Diagnosis","volume":"10","author":"Tavano","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.18632\/aging.202319","article-title":"miR-18a increases insulin sensitivity by inhibiting PTEN","volume":"13","author":"Zhou","year":"2020","journal-title":"Aging"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1096\/fj.09-138198","article-title":"Correlations between progression of coronary artery disease and circulating endothelial progenitor cells","volume":"24","author":"Briguori","year":"2010","journal-title":"FASEB J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.2337\/dc14-1720","article-title":"Type 1 diabetes mellitus and cardiovascular disease: A scientific statement from the American Heart Association and American Diabetes Association","volume":"37","author":"Fonseca","year":"2014","journal-title":"Diabetes Care"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Ray, S.L., Coulson, D.J., Yeoh, M.L.Y., Tamara, A., Latief, J.S., Bakhashab, S., and Weaver, J.U. (2020). The Role of miR-342 in Vascular Health. Study in Subclinical Cardiovascular Disease in Mononuclear Cells, Plasma, Inflammatory Cytokines and PANX2. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21197217"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1423-0127-19-34","article-title":"The role of thrombomodulin lectin-like domain in inflammation","volume":"19","author":"Li","year":"2012","journal-title":"J. Biomed. Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s13054-019-2552-0","article-title":"Thrombomodulin in disseminated intravascular coagulation and other critical conditions\u2014A multi-faceted anticoagulant protein with therapeutic potential","volume":"23","author":"Ito","year":"2019","journal-title":"Crit. Care"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/MBC.0000000000001035","article-title":"Soluble thrombomodulin and cardiovascular disease risk factors in Japanese children","volume":"32","author":"Kikuchi","year":"2021","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/S0140-6736(98)09057-6","article-title":"Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) Study: A case-cohort study","volume":"353","author":"Salomaa","year":"1999","journal-title":"Lancet"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"68122","DOI":"10.18632\/oncotarget.11828","article-title":"Thrombomodulin promotes focal adhesion kinase activation and contributes to angiogenesis by binding to fibronectin","volume":"7","author":"Hsu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1046\/j.1365-2141.2001.03077.x","article-title":"Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells","volume":"115","author":"Quirici","year":"2001","journal-title":"Br. J. Haematol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.exphem.2013.10.003","article-title":"Integrated analysis of miRNA and mRNA during differentiation of human CD34+ cells delineates the regulatory roles of microRNA in hematopoiesis","volume":"42","author":"Raghavachari","year":"2014","journal-title":"Exp. Hematol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2337\/dc09-1468","article-title":"Circulating Vascular Progenitor Cells in Patients with Type 1 Diabetes and Microalbuminuria","volume":"33","author":"Dessapt","year":"2010","journal-title":"Diabetes Care"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2337\/dc16-1755","article-title":"Long-term Prediction of Cardiovascular Outcomes by Circulating CD34+ and CD34 + CD133+ Stem Cells in Patients with Type 2 Diabetes","volume":"40","author":"Fadini","year":"2017","journal-title":"Diabetes Care"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/jdi.12310","article-title":"Decreased levels of circulating CD 34 + cells are associated with coronary heart disease in Japanese patients with type 2 diabetes","volume":"6","author":"Makino","year":"2015","journal-title":"J. Diabetes Investig."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Stacker, S., and Achen, M. (2018). Emerging Roles for VEGF-D in Human Disease. Biomolecules, 8.","DOI":"10.3390\/biom8010001"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1136\/heartjnl-2018-313684","article-title":"Increased vascular endothelial growth factor D is associated with atrial fibrillation and ischaemic stroke","volume":"105","author":"Berntsson","year":"2019","journal-title":"Heart"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jacc.2017.11.058","article-title":"Vascular Endothelial Growth Factor D, Pulmonary Congestion, and Incidence of Heart Failure","volume":"71","author":"Borne","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/01.CIR.102.2.185","article-title":"Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: A potential predictor for the individual capacity to develop collaterals","volume":"102","author":"Waltenberger","year":"2000","journal-title":"Circulation"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.3389\/fimmu.2018.01302","article-title":"The Clinical Significance and Potential Role of C-Reactive Protein in Chronic Inflammatory and Neurodegenerative Diseases","volume":"9","author":"Luan","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cardiores.2006.03.004","article-title":"C-reactive protein in atherosclerosis: A causal factor?","volume":"71","author":"Paffen","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1161\/01.CIR.102.18.2165","article-title":"Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells","volume":"102","author":"Pasceri","year":"2000","journal-title":"Circulation"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1161\/01.CIR.0000052617.91920.FD","article-title":"C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: Implications for the metabolic syndrome and atherothrombosis","volume":"107","author":"Devaraj","year":"2003","journal-title":"Circulation"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ejheart.2008.06.007","article-title":"Interleukin-10 improves left ventricular function in rats with heart failure subsequent to myocardial infarction","volume":"10","author":"Stumpf","year":"2008","journal-title":"Eur. J. Heart Fail."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"12120","DOI":"10.1038\/s41598-020-68995-z","article-title":"IL-10 attenuates OxPCs-mediated lipid metabolic responses in ischemia reperfusion injury","volume":"10","author":"Bagchi","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"40142","DOI":"10.1074\/jbc.M111.251793","article-title":"MicroRNA-18a enhances the interleukin-6-mediated production of the acute-phase proteins fibrinogen and haptoglobin in human hepatocytes","volume":"286","author":"Brock","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"E433","DOI":"10.1152\/ajpendo.00074.2003","article-title":"IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans","volume":"285","author":"Steensberg","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1365-3083.2006.01816.x","article-title":"Th1\/Th2 Imbalance, Measured by Circulating and Intracytoplasmic Inflammatory Cytokines\u2014Immunological Alterations in Acute Coronary Syndrome and Stable Coronary Artery Disease","volume":"64","author":"Szodoray","year":"2006","journal-title":"Scand. J. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"51697","DOI":"10.1074\/jbc.M410369200","article-title":"IRAK1 Serves as a Novel Regulator Essential for Lipopolysaccharide-induced Interleukin-10 Gene Expression","volume":"279","author":"Huang","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1111\/jcmm.13240","article-title":"Expression of miR-18a and miR-34c in circulating monocytes associated with vulnerability to type 2 diabetes mellitus and insulin resistance","volume":"21","author":"Wang","year":"2017","journal-title":"J. Cell. Mol. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"540","DOI":"10.4158\/EP.15.6.540","article-title":"Statement by an American Association of Clinical Endocrinologists\/American College of Endocrinology consensus panel on type 2 diabetes mellitus: An algorithm for glycemic control","volume":"15","author":"Rodbard","year":"2009","journal-title":"Endocr. Pract."},{"key":"ref_74","unstructured":"National Institute for Health and Care Excellence (2021, November 25). Type 1 Diabetes in Adults: Diagnosis and Management. Available online: http:\/\/www.nice.org.uk\/."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S2213-8587(17)30194-8","article-title":"Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): A double-blind, randomised, placebo-controlled trial","volume":"5","author":"Petrie","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"21782","DOI":"10.1038\/s41598-020-78871-5","article-title":"Long-term exposure of human endothelial cells to metformin modulates miRNAs and isomiRs","volume":"10","author":"Giuliani","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"28597","DOI":"10.1038\/srep28597","article-title":"Metformin is a novel suppressor for transforming growth factor (TGF)-beta1","volume":"6","author":"Xiao","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_78","first-page":"3947","article-title":"Metformin inhibits development of diabetic retinopathy through inducing alternative splicing of VEGF-A","volume":"8","author":"Yi","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13578-019-0297-8","article-title":"Cardioprotective effects of microRNA-18a on acute myocardial infarction by promoting cardiomyocyte autophagy and suppressing cellular senescence via brain derived neurotrophic factor","volume":"9","author":"Lin","year":"2019","journal-title":"Cell Biosci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1073\/pnas.95.2.548","article-title":"Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)","volume":"95","author":"Achen","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1016\/j.ijcard.2012.06.127","article-title":"Differential expression of vascular endothelial growth factor isoforms and receptor subtypes in the infarcted heart","volume":"167","author":"Zhao","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1093\/eurheartj\/ehx352","article-title":"Adenoviral intramyocardial VEGF-DDeltaNDeltaC gene transfer increases myocardial perfusion reserve in refractory angina patients: A phase I\/IIa study with 1-year follow-up","volume":"38","author":"Hartikainen","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/cvr\/cvr220","article-title":"Thrombomodulin domains attenuate atherosclerosis by inhibiting thrombin-induced endothelial cell activation","volume":"92","author":"Wei","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1538-7836.2006.02267.x","article-title":"Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: Results of a phase III, randomized, double-blind clinical trial","volume":"5","author":"Saito","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1161\/CIRCULATIONAHA.116.021805","article-title":"Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E\u2013Deficient Mice","volume":"133","author":"Higashi","year":"2016","journal-title":"Circulation"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e12390","DOI":"10.1111\/cpr.12390","article-title":"IGF-1 promotes angiogenesis in endothelial cells\/adipose-derived stem cells co-culture system with activation of PI3K\/Akt signal pathway","volume":"50","author":"Lin","year":"2017","journal-title":"Cell Prolif."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"12729","DOI":"10.1073\/pnas.97.23.12729","article-title":"Increased adipose tissue in male and female estrogen receptor-alpha knockout mice","volume":"97","author":"Heine","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"H1640","DOI":"10.1152\/ajpheart.2000.278.5.H1640","article-title":"Myocardial ischemia-reperfusion injury in estrogen receptor-alpha knockout and wild-type mice","volume":"278","author":"Zhai","year":"2000","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"16716","DOI":"10.1038\/s41598-017-16686-7","article-title":"Estrogen receptor 1 (ESR1) regulates VEGFA in adipose tissue","volume":"7","author":"Fatima","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1186\/s13287-020-01881-7","article-title":"HIF-1\u03b1 overexpression in mesenchymal stem cell-derived exosomes mediates cardioprotection in myocardial infarction by enhanced angiogenesis","volume":"11","author":"Sun","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.mvr.2010.09.008","article-title":"Mutant hypoxia inducible factor-1alpha improves angiogenesis and tissue perfusion in ischemic rabbit skeletal muscle","volume":"81","author":"Li","year":"2011","journal-title":"Microvasc. Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"H1291","DOI":"10.1152\/ajpheart.00604.2010","article-title":"Mechanisms of novel cardioprotective functions of CCN2\/CTGF in myocardial ischemia-reperfusion injury","volume":"300","author":"Ahmed","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Panek, A.N., Posch, M.G., Alenina, N., Ghadge, S.K., Erdmann, B., Popova, E., Perrot, A., Geier, C., Dietz, R., and Morano, I. (2009). Connective tissue growth factor overexpression in cardiomyocytes promotes cardiac hypertrophy and protection against pressure overload. PLoS ONE, 4.","DOI":"10.1371\/annotation\/818d7cc6-3ec0-4fc5-82e1-8e9b6ceca336"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"36790","DOI":"10.1038\/srep36790","article-title":"Protein Inhibitor of Activated STAT3 Suppresses Oxidized LDL-induced Cell Responses during Atherosclerosis in Apolipoprotein E-deficient Mice","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Yang, X., Jia, J., Yu, Z., Duanmu, Z., He, H., Chen, S., and Qu, C. (2020). Inhibition of JAK2\/STAT3\/SOCS3 signaling attenuates atherosclerosis in rabbit. BMC Cardiovasc. Disord., 20.","DOI":"10.1186\/s12872-020-01391-7"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Villar, A.V., Cobo, M., Llano, M., Montalvo, C., Gonzalez-Vilchez, F., Martin-Duran, R., Hurle, M.A., and Nistal, J.F. (2009). Plasma levels of transforming growth factor-beta1 reflect left ventricular remodeling in aortic stenosis. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0008476"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI0214190","article-title":"TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II","volume":"109","author":"Schultz","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Ferreira, R.R., Abreu, R.D.S., Vilar-Pereira, G., Degrave, W., Meuser-Batista, M., Ferreira, N.V.C., da Cruz Moreira, O., da Silva Gomes, N.L., Mello de Souza, E., and Ramos, I.P. (2019). TGF-beta inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas\u2019 heart disease. PLoS Negl. Trop. Dis., 13.","DOI":"10.1371\/journal.pntd.0007602"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"D127","DOI":"10.1093\/nar\/gkz757","article-title":"miRDB: An online database for prediction of functional microRNA targets","volume":"48","author":"Chen","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13059-019-1629-z","article-title":"Prediction of functional microRNA targets by integrative modeling of microRNA binding and target expression data","volume":"20","author":"Liu","year":"2019","journal-title":"Genome Biol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"W498","DOI":"10.1093\/nar\/gks494","article-title":"DIANA miRPath v.2.0: Investigating the combinatorial effect of microRNAs in pathways","volume":"40","author":"Vlachos","year":"2012","journal-title":"Nucleic Acids Res."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/9\/2136\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:20:56Z","timestamp":1760142056000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/9\/2136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,31]]},"references-count":101,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["biomedicines10092136"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10092136","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,31]]}}}